K.C. Kwan

1.9k total citations
33 papers, 1.5k citations indexed

About

K.C. Kwan is a scholar working on Pharmacology, Pharmacology and Oncology. According to data from OpenAlex, K.C. Kwan has authored 33 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 9 papers in Pharmacology and 9 papers in Oncology. Recurrent topics in K.C. Kwan's work include Drug Transport and Resistance Mechanisms (9 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Antibiotics Pharmacokinetics and Efficacy (8 papers). K.C. Kwan is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Antibiotics Pharmacokinetics and Efficacy (8 papers). K.C. Kwan collaborates with scholars based in United States, Japan and Belgium. K.C. Kwan's co-authors include K. C. Yeh, D E Duggan, F. Gilbert McMahon, G. O. Breault, R.M. Noll, K F Hooke, Bai‐Lin Lei, Elwood L. Foltz, K. Sandy Pang and D. J. Allen and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, International Journal of Pharmaceutics and Biochemical Pharmacology.

In The Last Decade

K.C. Kwan

33 papers receiving 1.4k citations

Peers

Replace M. Gibaldi with:

M. Gibaldi United States

J.C.K. Loo Canada

L Balant Switzerland

Dominick J. Tocco United States

K. C. Yeh United States

Mario L. Rocci United States

Robert A. Upton United States

William G. Crouthamel United States

James T. Doluisio United States

Douglas S. Greene United States

M. Gibaldi United States View profile →

Citations per field, relative to K.C. Kwan

K.C. Kwan · 1×

×0.9 441

PHARM

×1.3 421

PHARM

×1.3 345

ONCOL

×0.9 217

MB

×0.8 146

PS

Citations per year, relative to K.C. Kwan

K.C. Kwan · 1×

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

Countries citing papers authored by K.C. Kwan

Since Specialization

Citations

This map shows the geographic impact of K.C. Kwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.C. Kwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.C. Kwan more than expected).

Fields of papers citing papers by K.C. Kwan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.C. Kwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.C. Kwan. The network helps show where K.C. Kwan may publish in the future.

Co-authorship network of co-authors of K.C. Kwan

This figure shows the co-authorship network connecting the top 25 collaborators of K.C. Kwan. A scholar is included among the top collaborators of K.C. Kwan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.C. Kwan. K.C. Kwan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TD-5959: A Novel Bifunctional Muscarinic Antagonist – β ₂ -Adrenergic Agonist with Potent and Sustained In Vivo Bronchodilator Activity in Guinea Pigs. 2009 ·(unknown), Alexander McNamara, K.C. Kwan, Martin Wj, (unknown), M Mammen, Sharath S. Hegde	2
2	Comparative Preclinical Efficacy of Combivent and a Novel, Bifunctional Muscarinic Antagonist and β2-Adrenergic Agonist. 2009 ·Alexander McNamara, K.C. Kwan, Martin Wj, Eric L. Stangeland, Sharath S. Hegde, M Mammen, (unknown)	1
3	Oral bioavailability and first-pass effects. 1997 ·PubMed ·K.C. Kwan	74
4	Beta estimation for thinly traded shares: A bootstrap approach 1990 ·Omega ·(unknown), K.C. Kwan, (unknown)	2
5	A commentary: methods and assumptions in the kinetic estimation of metabolite formation. 1983 ·Drug Metabolism and Disposition ·K. Sandy Pang, K.C. Kwan	55
6	Elementary Osmotic Pump for Indomethacin 1983 ·Journal of Pharmaceutical Sciences ·Felix Theeuwes, David Swanson, (unknown), P.P.M. Bonsen, Virgil A. Place, (unknown), K.C. Kwan	45
7	Pharmacokinetic evaluation of osmotically controlled indomethacin delivery systems in man 1983 ·International Journal of Pharmaceutics ·John Rogers, (unknown), (unknown), R Ferguson, Richard O. Davies, Felix Theeuwes, K.C. Kwan	6
8	Stereoselectivity in the disposition and metabolism of the uricosuric-diuretic agent, indacrinone, in Rhesus monkeys. 1982 ·Drug Metabolism and Disposition ·Anthony G. Zacchei, Michael R. Dobrinska, (unknown), K.C. Kwan, (unknown)	13
9	Pharmacokinetics of Sulindac. 1980 ·PubMed ·K.C. Kwan, D E Duggan	14
10	Further Considerations on Model-Independent Bioavailability Estimation 1980 ·Journal of Pharmaceutical Sciences ·Stephen S. Hwang, K.C. Kwan	4
11	Enterohepatic Recirculation of Drugs as a Determinant of Therapeutic Ratio 1979 ·Drug Metabolism Reviews ·D E Duggan, K.C. Kwan	28
12	Pharmacokinetics of methyldopa in man. 1976 ·Journal of Pharmacology and Experimental Therapeutics ·K.C. Kwan, Elwood L. Foltz, G. O. Breault, (unknown), James A. Totaro	55
13	Bioavailability assessment under quasi‐ and nonsteady‐state conditions II: Study designs 1976 ·Journal of Pharmaceutical Sciences ·K. C. Yeh, K.C. Kwan	3
14	Bioavailability Assessment under Quasi- and Nonsteady-State Conditions III: Application 1976 ·Journal of Pharmaceutical Sciences ·Joseph V. Bondi, H. Hücker, K. C. Yeh, K.C. Kwan	2
15	Pharmacology and pharmacokinetics 1976 ·Journal of Pharmaceutical Sciences ·K.C. Kwan	7
16	Kinetics of indomethacin absorption, elimination, and enterohepatic circulation in man 1976 ·Journal of Pharmacokinetics and Biopharmaceutics ·K.C. Kwan, G. O. Breault, (unknown), F. Gilbert McMahon, D E Duggan	123
17	Bioavailability Assessment under Quasi-and Nonsteady-State Conditions I: Theoretical Considerations 1975 ·Journal of Pharmaceutical Sciences ·K.C. Kwan, (unknown), K. C. Yeh	6
18	An integrated approach to the pharmacokinetic analysis of drug absorption 1974 ·Journal of Pharmacokinetics and Biopharmaceutics ·(unknown), Leslie Z. Benet, K.C. Kwan	21
19	THE METABOLISM OF INDOMETHACIN IN MAN 1972 ·Journal of Pharmacology and Experimental Therapeutics ·D E Duggan, (unknown), K.C. Kwan, F. Gilbert McMahon	142
20	Dissolution Apparatus with Multiple Testing Stations 1968 ·Journal of Pharmaceutical Sciences ·(unknown), (unknown), (unknown), K.C. Kwan, (unknown)	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact